Edwards Lifesciences Long-Term Investments 2010-2024 | EW

Edwards Lifesciences long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • Edwards Lifesciences long-term investments for the quarter ending September 30, 2024 were $0.353B, a 58.74% decline year-over-year.
  • Edwards Lifesciences long-term investments for 2023 were $0.584B, a 52.87% decline from 2022.
  • Edwards Lifesciences long-term investments for 2022 were $1.239B, a 32.45% decline from 2021.
  • Edwards Lifesciences long-term investments for 2021 were $1.834B, a 128.82% increase from 2020.
Edwards Lifesciences Annual Long-Term Investments
(Millions of US $)
2023 $584
2022 $1,239
2021 $1,834
2020 $802
2019 $586
2018 $
2017 $567
2016 $532
2015 $380
2014 $241
2013 $22
2012 $21
2011 $22
2010 $25
2009 $22
Edwards Lifesciences Quarterly Long-Term Investments
(Millions of US $)
2024-06-30 $353
2024-03-31 $456
2023-12-31 $584
2023-09-30 $705
2023-06-30 $856
2023-03-31 $1,067
2022-12-31 $1,239
2022-09-30 $1,381
2022-06-30 $1,491
2022-03-31 $1,624
2021-12-31 $1,834
2021-09-30 $1,282
2021-06-30 $1,014
2021-03-31 $802
2020-12-31 $802
2020-09-30 $599
2020-06-30 $594
2020-03-31 $588
2019-12-31 $586
2019-09-30 $386
2019-06-30 $413
2019-03-31 $454
2018-12-31
2018-09-30 $479
2018-06-30 $470
2018-03-31 $532
2017-12-31 $567
2017-09-30 $568
2017-06-30 $552
2017-03-31 $519
2016-12-31 $532
2016-09-30 $468
2016-06-30 $392
2016-03-31 $369
2015-12-31 $380
2015-09-30 $366
2015-06-30 $325
2015-03-31 $256
2014-12-31 $241
2014-09-30 $92
2014-06-30 $99
2014-03-31 $95
2013-12-31 $22
2013-09-30 $21
2013-06-30 $22
2013-03-31 $23
2012-12-31 $21
2012-09-30 $23
2012-06-30 $22
2012-03-31 $22
2011-12-31 $22
2011-09-30 $21
2011-06-30 $25
2011-03-31 $27
2010-12-31 $25
2010-09-30 $22
2010-06-30 $22
2010-03-31 $22
2009-12-31 $22
2009-09-30 $25
2009-06-30 $20
2009-03-31 $17
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.340B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $209.197B 25.52
Intuitive Surgical (ISRG) United States $190.823B 99.77
Alcon (ALC) Switzerland $45.517B 32.04
IQVIA Holdings (IQV) United States $39.384B 21.70
IDEXX Laboratories (IDXX) United States $35.808B 42.17
DexCom (DXCM) United States $27.463B 41.36
Waters (WAT) United States $22.607B 33.43
SONOVA HOLDING (SONVY) Switzerland $22.062B 0.00
STERIS (STE) Ireland $21.899B 25.21
Hologic (HOLX) United States $18.440B 19.46
Sysmex ADR (SSMXY) Japan $12.915B 40.50
Fresenius Medical Care AG KGaA (FMS) Germany $12.552B 12.89
Globus Medical (GMED) United States $11.102B 28.27
Penumbra (PEN) United States $9.290B 91.00
Teleflex (TFX) United States $9.197B 14.67
Masimo (MASI) United States $8.654B 41.87
Glaukos (GKOS) United States $7.887B 0.00
PROCEPT BioRobotics (PRCT) United States $5.083B 0.00
Integer Holdings (ITGR) United States $4.679B 26.52
Inari Medical (NARI) United States $3.123B 0.00
Veracyte (VCYT) United States $3.014B 90.44
TransMedics (TMDX) United States $2.991B 94.80
LivaNova (LIVN) United Kingdom $2.813B 16.24
Nihon Kohden (NHNKY) Japan $2.554B 19.40
Elekta AB (EKTAY) Sweden $2.304B 18.77
Tandem Diabetes Care (TNDM) United States $2.060B 0.00
Integra LifeSciences Holdings (IART) United States $1.964B 10.26
RxSight (RXST) United States $1.867B 0.00
Alphatec Holdings (ATEC) United States $1.375B 0.00
Artivion (AORT) United States $1.210B 80.19
Pulse Biosciences (PLSE) United States $1.155B 0.00
OPKO Health (OPK) United States $1.072B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.951B 16.16
ORTHOFIX MEDICAL INC (OFIX) United States $0.764B 0.00
IRadimed (IRMD) United States $0.727B 39.28
Pacific Biosciences Of California (PACB) United States $0.670B 0.00
SiBone (SIBN) United States $0.664B 0.00
Mesa Laboratories (MLAB) United States $0.646B 15.23
Paragon 28 (FNA) United States $0.637B 0.00
AxoGen (AXGN) United States $0.615B 0.00
OrthoPediatrics (KIDS) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.516B 0.00
CVRx (CVRX) United States $0.384B 0.00
Tactile Systems Technology (TCMD) United States $0.383B 20.73
Semler Scientific (SMLR) United States $0.379B 25.43
Delcath Systems (DCTH) United States $0.318B 0.00
ClearPoint Neuro (CLPT) United States $0.315B 0.00
AngioDynamics (ANGO) United States $0.302B 0.00
Inogen (INGN) United States $0.262B 0.00
Sight Sciences (SGHT) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.213B 0.00
Atossa Genetics (ATOS) United States $0.204B 0.00
Accuray (ARAY) United States $0.199B 0.00
Nevro (NVRO) United States $0.198B 0.00
Alpha Tau Medical (DRTS) Israel $0.157B 0.00
KORU Medical Systems (KRMD) United States $0.132B 0.00
908 Devices (MASS) United States $0.125B 0.00
Sensus Healthcare (SRTS) United States $0.116B 17.19
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
EDAP TMS S.A (EDAP) France $0.094B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Covalon Technologies (CVALF) Canada $0.076B 0.00
Monogram Orthopaedics (MGRM) United States $0.076B 0.00
Vicarious Surgical (RBOT) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.066B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Rapid Micro Biosystems (RPID) United States $0.055B 0.00
Accelerate Diagnostics (AXDX) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Biosig Technologies (BSGM) United States $0.038B 0.00
Adagio Medical Holdings (ADGM) United States $0.035B 0.00
Neuronetics (STIM) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.026B 0.00
NexGel (NXGL) United States $0.022B 0.00
Baird Medical Investment Holdings (BDMD) $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00